Skip to main content
PLOS One logoLink to PLOS One
. 2024 Jul 19;19(7):e0307085. doi: 10.1371/journal.pone.0307085

A cross-sectional study of physicians on fluoride-related beliefs and practices, and experiences with fluoride-hesitant caregivers

Tiffany Bass 1, Courtney M Hill 2, Jennifer L Cully 3,4, Sophie R Li 2, Donald L Chi 1,2,*
Editor: Hadi Ghasemi5
PMCID: PMC11259263  PMID: 39028748

Abstract

The goal of this study was to describe medical providers’ fluoride-related beliefs and practices, experiences with fluoride-hesitant caregivers, and barriers to incorporating oral health activities into their practice. In this cross-sectional study, we specifically tested the hypothesis of whether these factors differed between pediatric and family medicine providers. A 39-item online survey was administered to a convenience sample of pediatric and family medicine providers in Washington state and Ohio (U.S.A.). Responses to the fluoride survey were compared between pediatric and family medicine providers with a chi-square test (α = 0.05). Of the 354 study participants, 45% were pediatric providers and 55% were family medicine providers. About 61.9% of providers believed fluoridated water was highly effective at preventing tooth decay while only 29.1% believed prescription fluoride supplements were highly effective. Nearly all providers recommend over-the-counter fluoride toothpaste (87.3%), 44.1% apply topical fluoride in clinic, and 30.8% prescribe fluoride supplements. Most providers reported fluoride hesitancy was a small problem or not a problem (82.5%) and the most common concerns patients raise about fluoride were similar to those raised about vaccines. Lack of time was the most commonly reported barrier to incorporating oral health into practice, which was more commonly reported by family medicine providers than pediatric providers (65.6% vs. 50.3%; p = .005). Pediatric and family medicine providers have early and frequent access to children before children visit a dentist. Improving the use of fluorides through children’s medical visits could improve pediatric oral health and reduce oral health inequities, especially for vulnerable populations at increased risk for tooth decay.

Introduction

Tooth decay (dental caries or cavities) is largely preventable but remains the most common chronic disease in children and disproportionately impacts those from low-income families [1]. Downstream consequences of childhood tooth decay include pain, hospitalizations, school absences, poor academic performance, and lower quality of life [24]. In line with anticipatory guidance recommended by the American Academy of Pediatric Dentistry to prevent tooth decay, the American Academy of Pediatrics and the American Academy of Family Physicians recommend that children receive their first dental visit by no later than age 12 months [57]. However, less than 2% of low-income children meet this recommendation [8]. In contrast, most children will see a medical provider for as many as seven well-child visits before age 12 months [9]. Thus, medical providers play a critical role in helping to ensure optimal oral health for children in early life [10]. However, medical providers experience barriers to integrating oral health-related anticipatory guidance and preventive oral health treatments like topical fluoride into practice [11].

Fluoride is the cornerstone of tooth decay prevention efforts. It is safe and effective [12]. There are multiple fluoride modalities, including topical fluoride (applied by a health care provider), prescription fluoride supplements, over-the-counter fluoride toothpaste and rinses, and fluoridated water. Fluoride supplements are indicated for children at high risk for tooth decay and those who live in an area without fluoridated water [13]. The American Academy of Pediatrics suggests that pediatricians 1) recommend fluoridated toothpaste to children at the eruption of the first tooth; and 2) apply topical fluoride to high risk children under age 6 years [14]. In addition, the American Academy of Pediatrics and the American Academy of Family Physicians guidelines support water fluoridation and recommend that medical providers determine the need for fluoride supplements based on water fluoridation status of the community in which the child lives [14,15].

There are multiple documented barriers to medical providers incorporating oral health-related anticipatory guidance and fluoride application into practice. Previous work suggests oral health training during medical school and residency is insufficient in shaping future provider behaviors [1618]. A study in Hawaii reported that a smaller proportion of family medicine providers were familiar with the American Dental Association’s recommendation for daily fluoride supplementation compared to pediatric providers (53% vs. 76%) [19]. Studies among pediatricians and family medicine providers in Saudi Arabia and in Canada have found that about one-half of providers report that lack of time is a barrier to carrying out oral health activities [18,20]. Similarly, medical providers may believe that providing treatments like fluoride is outside the scope of medical practice. Among pediatricians and family medicine providers in Saudi Arabia, pediatric providers had more positive attitudes about the need for medical providers to provide pediatric dental checks compared to family medicine providers [20].

Another potential barrier is discomfort communicating with caregivers who are hesitant about fluoride, which is a behavior linked to vaccine hesitancy [21]. Vaccine hesitant parents may raise issues that many providers feel ill-equipped to respond to because of inadequate training [22]. Physicians may request that vaccine-hesitant patients leave their practice due to frustration with patient pushback [23]. Research among pediatricians in Connecticut suggests that at least 30% of providers have dismissed families because of their refusal to immunize [24] and findings from a national survey of pediatricians in 2012 and 2013 showed that 12% to 21% of pediatricians reported always or often dismissing families who refused vaccines from their practice [25,26]. Dismissal for immunization refusal is discouraged by the Centers for Disease Control and Prevention and the American Academy of Pediatrics [23].

To date, there has been no research on medical providers’ experiences with topical fluoride hesitancy, but it is increasingly relevant because fluoride hesitancy is associated with vaccine hesitancy and both behaviors may be increasing in the United States [27]. Furthermore, it is unknown whether providers’ experiences with fluoride hesitancy differ by medical provider type. The goals of this study were to describe fluoride beliefs and practices, experiences with fluoride-hesitant caregivers, and barriers to incorporating oral health activities into practice among medical providers. We also determine whether each differed between pediatric providers and family medicine providers. Because medical providers play a critical role in tooth decay prevention, the findings from this study are expected to be relevant in improving fluoride policies in medical practice.

Materials and methods

Study design, setting, and participants

This cross-sectional study focused on four types of medical providers in Washington state and Ohio: Medical Doctors (MDs), Osteopathic Doctors (DOs), Physician Assistants (PAs), and Nurse Practitioners (NPs). In Washington, a convenience sample of participants was recruited via email from four sources: medical directors at the Community Health Plan of Washington, medical providers at Community Health Plan of Washington (n = 91), members of the Washington Academy of Family Physicians, and all MDs with an active license in Washington (n = 20,868 active MDs with an active email address). In Ohio, participants were recruited among pediatric medical providers who subscribed to the Cincinnati Children’s Hospital Medical Center Physician Outreach and Engagement newsletter. Medical providers invited to the study were asked to forward our study email to other medical colleagues who might be interested. To be included in the study, there were two eligibility criteria. First, participants had to treat at least one patient under age 18 years. Second, participants had to be a pediatric- or family medicine-focused provider. Informed consent was obtained from all participants with survey initiation as agreement to participate in the research (there was no written or verbal consent obtained). The study was classified as exempt by the Institutional Review Boards at University of Washington (IRB ID: STUDY00012846) and Cincinnati Children’s Hospital Medical Center (IRB ID: 2021–0228).

Data collection

From March 1, 2021 to September 30, 2021, medical providers were contacted via email with a link to an anonymous 39-item Research Electronic Data Capture (REDCap) questionnaire [see S1 File]. The survey included five sections: provider demographic and practice characteristics, beliefs on fluoride effectiveness, current fluoride-related practices, experiences with fluoride- and vaccine-hesitant caregivers, and barriers to incorporating oral health into practice.

Variables

Provider type

The main grouping variable in this study was self-reported provider type. The two groups were pediatric-focused provider vs. family medicine-focused provider.

Demographic, professional, and practice characteristics

The questionnaire included nine items on demographic, professional, and practice characteristics. Demographic characteristics included four items: age, gender, race, and ethnicity. Professional and practice characteristics included five items: provider type (physician, nurse practitioner, physician assistant), years since completing residency or clinical training, practice setting (university or hospital, community health center or public health clinic, private practice, military clinic), % of practice patients insured by Medicaid (0%, 1–25%, 26–50%, 51–75%, >75%), and whether they practiced in an area with fluoridated water (yes/no/unknown).

Beliefs on fluoride effectiveness

Providers’ beliefs about fluoride effectiveness in preventing cavities were assessed for five fluoride modalities: fluoride (in general), topical fluoride, prescription fluoride supplements, over-the-counter fluoride toothpaste, and fluoridated water. Each item had four response options: very effective, effective, somewhat effective, and not effective.

Fluoride-related practices

We assessed current practices for three fluoride modalities: topical fluoride application, fluoride supplement prescription, and over-the-counter fluoride toothpaste recommendation. Providers were asked whether they apply, prescribe, or recommend each fluoride modality (yes/no). Among providers who responded yes, we asked at what patient age they start applying, prescribing, or recommending the fluoride modality (<6 months, 6 months to ≤3 years, >3 years to ≤6 years, >6 years). When providers indicated they did not apply, prescribe, or recommend the fluoride modality, we provided a checklist to assess the reason(s) why. The checklist included options such as “my patients live in an area with fluoridated water”, “my patients are low risk for cavities”, and an open-ended option where providers could write-in other reasons. All open-ended responses were reviewed and then grouped into new categories.

Experiences with fluoride and vaccine hesitancy

To measure providers’ experiences with fluoride- and vaccine-hesitant caregivers, we used five items for each fluoride and vaccines (ten items total). The five items were “how often do parents/patients ask you for advice about fluoride/vaccines? (never, sometimes, often, always)”, “what issues do patients/parents raise about fluoride/vaccines?”, “how problematic is fluoride/vaccine hesitancy among patients in your practice? (a big problem, a medium-sized problem, a small problem, not a problem at all)”, “over time, fluoride/vaccine hesitancy among patients in your practice has (gotten worse, stayed the same, gotten better, I don’t know)”, and “when you encounter a parent who is hesitant about fluoride/vaccines, how comfortable are you talking to the parent about changing their mind about fluoride/vaccines? (extremely comfortable, somewhat comfortable, somewhat uncomfortable, extremely uncomfortable)”. The item on issues patients/parents raise was only presented to providers who indicated that parents/patients at least sometimes ask for advice and was a checklist that consisted of four issues that patients/parents raise (i.e., side effects, unsure of whether their child needs it, conflicting advice from another healthcare provider, cost).

Barriers to incorporating oral health into practice

An item checklist was used to identify barriers to incorporating oral health activities into practice. Response options included “lack of time”, “need to address other more important issues during medical visits”, “lack of knowledge”, “lack of parent/patient interest”, “belief that oral health activities should be performed by dentists”, “lack of dentists in the area for referral”, and “lack of reimbursement”. An open-ended response option was also included.

Statistical methods

First, provider demographic, professional, and practice characteristics were summarized as mean and standard deviation (SD) or n and %. Then, fluoride survey responses were summarized for the total study population and separately by provider type (pediatric providers vs. family medicine providers). Survey responses were not further stratified by provider type categories (physician vs. NP vs. PA) because there were few responses from NPs and PAs. Differences in fluoride survey responses by provider type were tested using the t-test or chi-square test (α = 0.05). Pairwise deletion was used to account for missing values in the analysis. All statistical analyses were conducted with R version 4.1.2.

Results

Demographic, professional, and practice characteristics

A total of 777 individuals accessed the survey and 657 initiated the survey. After removing surveys from individuals who indicated they were neither a pediatrician nor a family medicine provider (n = 239), did not treat patients under 18 years (n = 13), and those with missing data on provider type (n = 51), the final sample size was 354. Most providers screened out based on not being a pediatric- or family medicine-focused provider reported that they were dentists or pediatric medical specialists (e.g., emergency medicine, pulmonology).

Pediatric providers constituted 44.9% of the study sample (n = 159) and family medicine providers constituted 55.1% (n = 195) (Table 1). The mean age of the sample was 48.7 years (SD 19.6), most participants were women (65.0%), white (81.4%), and non-Hispanic (93.5%). Pediatric providers and family providers were similar across all other measured demographic characteristics. Almost all providers in the study were physicians (95.5%), 2.8% were NPs, and 1.7% were PAs. Pediatric providers tended to have a longer number of years since completing residency/clinical training than family medicine providers (66.7% vs. 54.3% had been practicing for more than 10 years; p = .01). Pediatric providers more commonly practiced in a private setting compared to family medicine providers but less commonly in community health centers or public health clinics compared to family medicine providers (55.3% vs. 20.0% and 20.1% vs. 49.7%; p < .001). The majority of both provider types reported that less than 50% of patients in their practice were publicly insured (e.g., by Medicaid) (61.3%) and that they practiced in an area with fluoridated water (66.9%).

Table 1. Demographic, professional, and practice characteristics of pediatric (n = 159) and family medicine providers (n = 195) in study.

Demographic, professional, and practice characteristics All providers
(N = 354)
Mean (SD) or n (%)
Pediatric provider
(n = 159)
Mean (SD) or n (%)
Family medicine provider
(n = 195)
Mean (SD) or n (%)
P-value2
Age (years) 48.7 (19.6) 47.4 (12.0) 49.8 (24.3) .29
Gender .30
Man 114 (32.2%) 45 (28.3%) 69 (35.4%)
Woman 230 (65.0%) 111 (69.8%) 119 (61.0%)
Non-binary 2 (0.6%) 1 (0.6%) 1 (0.5%)
Missing 8 (2.3%) 2 (1.3%) 6 (3.1%)
Race .07
American Indian or Alaska Native 2 (0.6%) 0 (0.0%) 2 (1.0%)
Asian 37 (10.5%) 20 (12.6%) 17 (8.7%)
Black or African American 9 (2.5%) 6 (3.8%) 3 (1.5%)
Native Hawaiian or Pacific Islander 1 (0.3%) 0 (0.0%) 1 (0.5%)
White 288 (81.4%) 130 (81.8%) 158 (81.0%)
Multi-racial 5 (1.4%) 1 (0.6%) 4 (2.1%)
Other1 6 (1.7%) 0 (0.0%) 6 (3.1%)
Missing 6 (1.7%) 2 (1.3%) 4 (2.1%)
Hispanic .43
Yes 18 (5.1%) 6 (3.8%) 12 (6.2%)
No 331 (93.5%) 151 (95.0%) 180 (92.3%)
Provider type .23
Physician 338 (95.5%) 155 (97.5%) 183 (93.8%)
Nurse Practitioner 10 (2.8%) 3 (1.9%) 7 (3.6%)
Physician Assistant 6 (1.7%) 1 (0.6%) 5 (2.6%)
Time since completing residency/clinical training .01
0–5 years 89 (25.1%) 27 (17.0%) 62 (31.8%)
6–10 years 53 (15.0%) 26 (16.4%) 27 (13.8%)
11–20 years 82 (23.2%) 47 (29.6%) 35 (17.9%)
21–30 years 83 (23.4%) 39 (24.5%) 44 (22.6%)
> 30 years 47 (13.3%) 20 (12.6%) 27 (13.8%)
Practice setting < .001
University or hospital 59 (16.7%) 34 (21.4%) 25 (12.8%)
Community health center/public health clinic 129 (36.4%) 32 (20.1%) 97 (49.7%)
Private practice 127 (35.9%) 88 (55.3%) 39 (20.0%)
Other 38 (10.7%) 5 (3.1%) 33 (16.9%)
Patients in practice insured by Medicaid .21
0% 9 (2.5%) 3 (1.9%) 6 (3.1%)
1–25% 122 (34.5%) 64 (40.3%) 58 (29.7%)
26–50% 86 (24.3%) 39 (24.5%) 47 (24.1%)
51–75% 75 (21.2%) 28 (17.6%) 47 (24.1%)
> 75% 59 (16.7%) 23 (14.5%) 36 (18.5%)
Missing 3 (0.8%) 2 (1.3%) 1 (0.5%)
Practices in an area with fluoridated water .03
Yes 237 (66.9%) 117 (73.6%) 120 (61.5%)
No 91 (25.7%) 34 (21.4%) 57 (29.2%)
Unknown 20 (5.6%) 5 (3.1%) 15 (7.7%)
Missing 6 (1.7%) 3 (1.9%) 3 (1.5%)

SD, standard deviation.

1Other race includes individuals who identified as Mexican-American, Latino, Latinx, or selected “other” race and did not specify further.

2P-values were generated using a t-test for age and a chi-square test for categorical variables. Missing values were removed before testing.

Beliefs on fluoride effectiveness

About 75.7% of providers believed that fluoride, in general, was very effective in preventing cavities (Table 2). Fluoridated water and topical fluoride were believed to be very effective by 61.9% and 48.9% of providers, respectively. Only 29.1% and 28.5% of providers believed that prescription fluoride supplements and OTC fluoride toothpaste were very effective. Larger proportions of pediatric providers believed fluoride was very effective, in general, and across all modalities, but only beliefs about the effectiveness of fluoride in general differed significantly by provider type (82.4% vs. 70.3%; p = .04).

Table 2. Pediatric (n = 159) and family medicine providers (n = 195) beliefs about the effectiveness of fluoride.

Beliefs about the effectiveness of fluoride modalities in preventing cavities All providers
(N = 354)
n (%)
Pediatric provider (n = 159)
n (%)
Family medicine provider
(n = 195)
n (%)
P-value1
Fluoride, in general     .04
Very effective 268 (75.7%) 131 (82.4%) 137 (70.3%)  
Effective 77 (21.8%) 26 (16.4%) 51 (26.2%)  
Somewhat effective 5 (1.4%) 1 (0.6%) 4 (2.1%)  
Not effective 2 (0.6%) 0 (0.0%) 2 (1.0%)  
Missing 2 (0.6%) 1 (0.6%) 1 (0.5%)
Topical fluoride     .07
Very effective 173 (48.9%) 88 (55.3%) 85 (43.6%)  
Effective 149 (42.1%) 62 (39.0%) 87 (44.6%)  
Somewhat effective 27 (7.6%) 7 (4.4%) 20 (10.3%)  
Not effective 2 (0.6%) 1 (0.6%) 1 (0.5%)  
Missing 3 (0.8%) 1 (0.6%) 2 (1.0%)
Prescription fluoride supplements    
Very effective 103 (29.1%) 52 (32.7%) 51 (26.2%) .10 
Effective 136 (38.4%) 63 (39.6%) 73 (37.4%)  
Somewhat effective 74 (20.9%) 31 (19.5%) 43 (22.1%)  
Not effective 31 (8.8%) 8 (5.0%) 23 (11.8%)  
Missing 10 (2.8%) 5 (3.1%) 5 (2.6%)
OTC fluoride toothpaste     .09
Very effective 101 (28.5%) 53 (33.3%) 48 (24.6%)  
Effective 156 (44.1%) 72 (45.3%) 84 (43.1%)  
Somewhat effective 86 (24.3%) 30 (18.9%) 56 (28.7%)  
Not effective 9 (2.5%) 3 (1.9%) 6 (3.1%)  
Missing 2 (0.6%) 1 (0.6%) 1 (0.5%)
Fluoridated water     .05
Very effective 219 (61.9%) 108 (67.9%) 111 (56.9%)  
Effective 104 (29.4%) 42 (26.4%) 62 (31.8%)  
Somewhat effective 26 (7.3%) 9 (5.7%) 17 (8.7%)  
Not effective 5 (1.4%) 0 (0.0%) 5 (2.6%)  

OTC, over-the-counter.

1P-values were generated using a chi-square test and missing values were removed before testing.

Fluoride-related practices

About 44.1% of providers reported applying topical fluoride in clinical practice, 30.8% reported prescribing fluoride supplements, and 87.3% reported recommending OTC fluoride toothpaste (Table 3). A significantly larger proportion of pediatric providers reported recommending OTC fluoride toothpaste than family medicine providers (92.5% vs. 83.1%; p = .01). There was no difference by provider type in the proportions who applied topical fluoride (p = .24) or prescribed fluoride supplements (p = .60).

Table 3. Fluoride-related practices by fluoride modality among pediatric (n = 159) and family medicine providers (n = 195).

Current fluoride-related practices by fluoride modality All providers
(N = 354)
n (%)
Pediatric provider (n = 159)
n (%)
Family medicine provider
(n = 195)
n (%)
P-value1
Applies topical fluoride .24
Yes 156 (44.1%) 64 (40.3%) 92 (47.2%)
No 194 (54.8%) 93 (58.5%) 101 (51.8%)
Missing 4 (1.1%) 2 (1.3%) 2 (1.0%)
Recommended age to start topical fluoride application Among providers who indicated they apply topical fluoride n = 156 n = 64 n = 92
<6 months 9 (5.8%) 3 (4.7%) 6 (6.5%)
6 months to ≤3 years 137 (87.8%) 59 (92.2%) 78 (84.8%)
3 to ≤6 years 7 (4.5%) 1 (1.6%) 6 (6.5%)
>6 years 2 (1.3%) 1 (1.6%) 1 (1.1%)
Missing 1 (0.6%) 0 (0.0%) 1 (1.1%)
Reasons for not applying topical fluoride Among providers who indicated they do not apply topical fluoride n = 194 n = 93 n = 101
Administrative barriers 76 (39.2%) 35 (37.6%) 41 (40.6%)
Patients live in an area with fluoridated water 54 (27.8%) 31 (33.3%) 23 (22.8%)
Patients receive this care from dentists 47 (24.2%) 17 (18.3%) 30 (29.7%)
Patients are at low risk for cavities 14 (7.2%) 11 (11.8%) 3 (3.0%)
There is no longer a need 1 (0.5%) 0 (0.0%) 1 (1.0%)
Many of my patients are hesitant 5 (2.6%) 2 (2.2%) 3 (3.0%)
Other (e.g., works in a subspecialty or urgent care) 27 (13.9%) 19 (20.4%) 8 (7.9%)
Prescribes fluoride supplements .60
Yes 109 (30.8%) 46 (28.9%) 63 (32.3%)
No 244 (68.9%) 112 (70.4%) 132 (67.7%)
Missing 1 (0.3%) 1 (0.6%) 0 (0.0%)
Recommended age to start prescribing fluoride supplements Among providers who indicated they prescribe fluoride supplements n = 109 n = 46 n = 63
<6 months 8 (7.3%) 3 (6.5%) 5 (7.9%)
6 months to ≤3 years 98 (89.9%) 42 (91.3%) 56 (88.9%)
3 to ≤6 years 3 (2.8%) 1 (2.2%) 2 (3.2%)
>6 years 0 (0.0%) 0 (0.0%) 0 (0.0%)
Reasons for not prescribing fluoride supplements Among providers who indicated they do not prescribe fluoride supplements n = 244 n = 112 n = 132
Patients live in an area with fluoridated water 164 (67.2%) 81 (72.3%) 83 (62.9%)
Patients are hesitant 30 (12.3%) 8 (7.1%) 22 (16.7%)
Patients have barriers to filling prescriptions 27 (11.1%) 5 (4.5%) 22 (16.7%)
Lack of knowledge about prescription fluoride 23 (9.4%) 9 (8.0%) 14 (10.6%)
My patients are low risk for cavities 11 (4.5%) 6 (5.4%) 5 (3.8%)
There is no longer a need 12 (4.9%) 5 (4.5%) 7 (5.3%)
Other 39 (16.0%) 20 (17.9%) 19 (14.4%)
Recommends OTC fluoride toothpaste .01
Yes 309 (87.3%) 147 (92.5%) 162 (83.1%)
No 42 (11.9%) 11 (6.9%) 31 (15.9%)
Missing 3 (0.8%) 1 (0.6%) 2 (1.0%)
Recommended age to start using OTC fluoride toothpaste Among providers who indicated they recommend OTC fluoride toothpaste n = 309 n = 147 n = 162
<6 months 18 (5.8%) 9 (6.1%) 9 (5.6%)
6 months to ≤3 years 205 (66.3%) 106 (72.1%) 99 (61.1%)
3 to ≤6 years 74 (23.9%) 29 (19.7%) 45 (27.8%)
>6 years 12 (3.9%) 3 (2.0%) 9 (5.6%)
Reasons for not recommending OTC fluoride toothpaste Among providers who indicated they do not recommend OTC fluoride toothpaste n = 42 n = 11 n = 31
Patients live in an area with fluoridated water 14 (33.3%) 2 (18.2%) 12 (38.7%)
Never specifies whether toothpaste has fluoride 10 (23.8%) 1 (9.1%) 9 (29.0%)
Many of my patients are hesitant 4 (9.5%) 0 (0.0%) 4 (12.9%)
There is no longer a need 2 (4.8%) 0 (0.0%) 2 (6.5%)
My patients are low risk for cavities 0 (0.0%) 0 (0.0%) 0 (0.0%)
Other 14 (33.3%) 8 (72.7%) 6 (19.3%)

OTC, over-the-counter.

1P-values were generated using a chi-square test and missing values were removed before testing.

Experiences with fluoride and vaccine hesitancy

Only 6.2% of providers reported that parents/patients always or often ask for advice about fluoride while 76.5% reported that patients always or often ask for advice about vaccines (Table 4). A significantly larger proportion of family medicine providers reported that parents/patients never ask for advice about fluoride compared to pediatric providers (49.2% vs. 21.3%; p = .002). The most common issues parents/patients raised about fluoride were similar to the issues raised about vaccines: being unsure if child needs it, side effects, and conflicting advice from another healthcare provider. Almost all (82.5%) of providers reported that fluoride hesitancy was a small problem or not a problem, 7.9% thought that it had gotten worse, and 82.5% reported that they were somewhat or extremely comfortable talking to hesitant patients about fluoride. About 51.3% of providers reported that vaccine hesitancy was a medium-sized or big problem, 48.3% reported that vaccine hesitancy had gotten worse, and 96.9% reported feeling somewhat or extremely comfortable talking to patients about vaccine hesitancy.

Table 4. Experiences with fluoride- and vaccine-hesitant parents among pediatric (n = 159) and family medicine providers (n = 195).

Experiences with fluoride and vaccine hesitancy All providers
(N = 354)
n (%)
Pediatric provider (n = 159)
n (%)
Family medicine provider
(n = 195)
n (%)
P-value1
Parents/patients ask for advice about fluoride… .002
Always 0 (0.0%) 0 (0.0%) 0 (0.0%)
Often 22 (6.2%) 9 (5.7%) 13 (6.7%)
Sometimes 185 (52.3%) 99 (62.3%) 86 (44.1%)
Never 146 (41.2%) 50 (31.4%) 96 (49.2%)
Missing 1 (0.3%) 1 (0.6%) 0 (0.0%)
Parents/patients raise these issues about fluoride… Among providers who indicated parents/patients ask for advice always, often, or sometimes n = 207 n = 108 n = 99
Unsure of whether child needs it 146 (70.5%) 77 (71.3%) 69 (69.7%)
Side effects 77 (37.2%) 42 (38.9%) 36 (36.4%)
Conflicting advice from another healthcare provider 51 (24.6%) 33 (30.5%) 19 (19.2%)
Cost 8 (3.9%) 2 (0.9%) 6 (6.1%)
Other 12 (5.8%) 6 (0.9%) 6 (6.1%)
Fluoride hesitancy is a… .53
Big problem 10 (2.8%) 3 (1.9%) 7 (3.6%)
Medium- sized problem 47 (13.3%) 18 (11.3%) 29 (14.9%)
Small problem 162 (45.8%) 77 (48.4%) 85 (43.6%)
Not a problem 130 (36.7%) 59 (37.1%) 71 (36.4%)
Missing 5 (1.4%) 2 (1.3%) 3 (1.5%)
Over time, fluoride hesitancy has… .54
Gotten worse (more parents are refusing) 28 (7.9%) 12 (7.5%) 16 (8.2%)
Stayed about the same 135 (38.1%) 61 (38.4%) 74 (37.9%)
Gotten better (fewer parents are refusing) 38 (10.7%) 21 (13.2%) 17 (8.7%)
I don’t know 152 (42.9%) 64 (40.3%) 88 (45.1%)
Missing 1 (0.3%) 1 (0.6%) 0 (0.0%)
Provider comfort with fluoride hesitancy .06
Extremely comfortable 110 (31.1%) 56 (35.2%) 54 (27.7%)
Somewhat comfortable 182 (51.4%) 80 (50.3%) 102 (52.3%)
Somewhat uncomfortable 50 (14.1%) 22 (13.8%) 28 (14.4%)
Extremely uncomfortable 7 (2.0%) 0 (0.0%) 7 (3.6%)
Missing 5 (1.4%) 1 (0.6%) 4 (2.1%)
Parents/ patients ask for advice about vaccines… .03
Always 74 (20.9%) 44 (27.7%) 30 (15.4%)
Often 197 (55.6%) 84 (52.8%) 113 (57.9%)
Sometimes 78 (22.0%) 30 (18.9%) 48 (24.6%)
Never 1 (0.3%) 0 (0.0%) 1 (0.5%)
Missing 4 (1.1%) 1 (0.6%) 3 (1.5%)
Parents/patients raise these issues about vaccines… Among providers who indicated parents/patients ask for advice always, often, or sometimes n = 349 n = 158 n = 191
Side effects 326 (93.4%) 153 (96.8%) 173 (90.6%)
Unsure of whether child needs It 246 (70.5%) 114 (72.2%) 132 (69.1%)
Conflicting advice from another healthcare provider 98 (28.1%) 41 (25.9%) 57 (29.8%)
Cost 17 (4.9%) 4 (2.5%) 13 (6.8%)
Other 39 (11.2%) 15 (9.5%) 24 (12.6%)
Vaccine hesitancy is a… .52
Big problem 67 (18.9%) 31 (19.5%) 36 (18.5%)
Medium- sized problem 150 (42.4%) 61 (38.4%) 89 (45.6%)
Small problem 130 (36.7%) 63 (39.6%) 67 (34.4%)
Not a problem 5 (1.4%) 3 (1.9%) 2 (1.0%)
Missing 2 (0.6%) 1 (0.6%) 1 (0.5%)
Vaccine hesitancy has… .09
Gotten worse (more parents are refusing) 171 (48.3%) 73 (45.9%) 98 (50.3%)
Stayed about the same 110 (31.1%) 46 (28.9%) 64 (32.8%)
Gotten better (fewer parents are refusing) 43 (12.1%) 27 (17.0%) 16 (8.2%)
I don’t know 28 (7.9%) 12 (7.5%) 16 (8.2%)
Missing 2 (0.6%) 1 (0.6%) 1 (0.5%)
Provider comfort with vaccine hesitancy .66
Extremely comfortable 252 (71.2%) 117 (73.6%) 135 (69.2%)
Somewhat comfortable 91 (25.7%) 37 (23.3%) 54 (27.7%)
Somewhat uncomfortable 4 (1.1%) 1 (0.6%) 3 (1.5%)
Extremely uncomfortable 5 (1.4%) 2 (1.3%) 3 (1.5%)
Missing 2 (0.6%) 2 (1.3%) 0 (0.0%)

1P-values were generated using a chi-square test and missing values were removed before testing.

Barriers to incorporating oral health into practice

The most common reported barriers to incorporating oral health into practice were lack of time (58.8% of all providers), the need to address more important issues during medical visits (50.0%), lack of knowledge (33.1%), and lack of parent/patient interest (27.4%) (Table 5). Family medicine providers were significantly more likely to report lack of time as a barrier compared to pediatric providers (65.6% vs. 50.3%; p = .005). There were no other significant differences in reported barriers by provider type.

Table 5. Barriers to incorporating oral health into practice among pediatric (n = 159) and family medicine providers (n = 195).

Barriers to incorporating oral health activities All providers
(N = 354)
n (%)1
Pediatric provider (n = 159)
n (%)
Family medicine provider
(n = 195)
n (%)
P-value2
Lack of time 208 (58.8%) 80 (50.3%) 128 (65.6%) .005
Need to address other more important issues during medical visits 177 (50.0%) 71 (44.7%) 106 (54.4%) .09
Lack of knowledge 117 (33.1%) 51 (32.1%) 66 (33.8%) .81
Lack of parent/patient interest 97 (27.4%) 39 (24.5%) 58 (29.7%) .33
Lack of reimbursement 45 (12.7%) 26 (16.4%) 19 (9.7%) .09
Belief these activities should be performed by dentists 58 (16.4%) 24 (15.1%) 34 (17.4%) .65
Lack of dentists in the area for referral 29 (8.2%) 13 (8.2%) 16 (8.2%) .99
Other 30 (8.5%) 15 (9.4%) 15 (7.7%) .69

1 The columns do not sum to 100% because participants were instructed to select each barrier that applies.

2 P-values were generated using a chi-square test.

Discussion

In this study, we examined fluoride-related beliefs and practices of pediatric and family medicine providers, their clinical experiences with fluoride-hesitant caregivers, and barriers to incorporating oral health activities into practice. There were three main findings. First, most providers believed fluoride prevents cavities and while nearly all recommended fluoride toothpaste, less than one-half applied topical fluoride in clinic. Second, relatively few providers reported fluoride hesitancy being a problem in clinic though caregiver concerns about fluoride mirrored concerns raised about vaccines. Third, the most common barriers to incorporating oral health into practice were lack of time and the need to address other issues during visits.

Most providers believed in the effectiveness of fluoride. More than 75% of providers in our study believed fluoride was very effective at preventing cavities, which aligns with previous research [28]. A significantly larger proportion of pediatric providers believed fluoride was very effective compared to family medicine providers (82.4% vs. 70.3%; P = 0.04), which may be influenced by greater knowledge about fluoride. Previous research found that pediatricians were more likely to correctly answer fluoride-related questions and report greater confidence in their knowledge about fluoride than family medicine providers [29], suggesting that fluoride guidance has been disseminated differentially across medical specialties. Another explanation is that interprofessional education on oral health has focused primarily on pediatrics [30], which highlights the potential for future efforts within non-pediatrics-focused primary care specialties, including family medicine, internal medicine, and obstetrics and gynecology.

Beliefs about the effectiveness of fluoride in preventing cavities differed by fluoride modality. About 61.9% of providers thought fluoridated water was very effective, whereas 48.9%, 29.1%, and 28.5% thought topical fluoride, prescription fluoride supplements, and OTC fluoride toothpaste were very effective, respectively. There are currently no studies on modality-focused fluoride beliefs among medical providers. Future studies should explore strategies to increase clinical support for different fluoride modalities, which could translate into greater knowledge among caregivers, greater alignment of preventive care messaging between medical and dental health care providers, and improvements in children’s oral health [31].

Providers reported incorporating fluoride into their current practices and recommending different types of fluoride to prevent cavities. About 87.3% of all providers recommended OTC fluoride toothpaste, 44.1% reported applying topical fluoride in clinic, and 30.8% prescribed fluoride supplements. A greater proportion of pediatric providers in our study reported recommending OTC fluoride toothpaste than family medicine providers (92.5% vs. 83.1%). This difference may be influenced by different training and academic practice guidelines between pediatric and family medicine providers. The American Academy of Pediatrics recommends that fluoride toothpaste be used at the eruption of the first tooth [6,14]. In a study of Canadian pediatricians and family physicians, pediatricians received more training and attended more Continuing Medical Education courses on oral health than family physicians [18]. In general, previous research has suggested that oral health training during medical school and residency is insufficient [16,17]. Future research should explore ways to improve fluoride-related practices in medical settings.

Providers reported their experiences with caregivers asking for advice about fluoride and vaccines, as well as their comfortability addressing fluoride hesitancy and vaccine hesitancy. A greater proportion of pediatric providers reported parents asking about fluoride (68%) compared to family medicine providers (50.8%). We observed a similar trend with vaccines. However, a greater proportion of providers reported that patients ask about vaccines compared to fluoride (98.5% vs. 58.5%). This difference may be because vaccines are a routine part of primary medical care as well as an emphasis on vaccines that increased during the COVID-19 pandemic [32], leading to greater public awareness and sensitivities about vaccines. In addition, about 96.9% of providers reported feeling somewhat or extremely comfortable talking to patients about vaccine hesitancy, while only 82.5% reported feeling somewhat or extremely comfortable talking to patients about fluoride hesitancy. No known studies have focused on medical providers’ comfort addressing fluoride hesitancy, though a study of general dentists and pediatric dentists in Washington state found fluoride refusal to be a significant problem in clinical practice, with large numbers of dentists feeling uncomfortable talking to caregivers who refused fluoride [27]. Given the associations between vaccine and fluoride hesitancy [21], strategies for addressing vaccine hesitancy may be applicable in addressing fluoride hesitancy. Such strategies include seeking to understand patient concerns and providing clarification in a nonjudgmental way [27].

The most common reported barrier to incorporating oral health into practice among providers was lack of time. About 58.8% of all providers reported lack of time as a barrier, which aligns with previous research [17,18,20]. In our study, family medicine providers were significantly more likely to report lack of time as a barrier compared to pediatric providers (65.6% vs. 50.3%). This barrier may be related to scope of practice. While pediatric providers focus on children, family medicine providers treat acute and chronic conditions for patients of all ages. Practice breadth may factor into the lack of time reported by family medicine providers, thus limiting their ability to incorporate oral health into visits. However, prior findings have indicated that medical providers express a positive attitude and willingness to engage in promoting the oral health of children [16,17]. Several programs have documented successful implementation of oral health activities in medical settings. One study found that including fluoride application in patient visits did not affect clinic flow and that adherence was high once a protocol was developed [33]. Another study demonstrated that brief education interventions and stop measures in electronic health record systems improved fluoride applications [34]. To overcome administrative barriers, some have found that dental hygienists incorporated into medical settings helped improve consistency and address lack of oral health knowledge among medical providers [35]. Future research should explore feasible ways oral health messaging can be meaningfully incorporated into practice.

There are two study limitations. First, the use of convenience sampling in two states limits generalizability. Second, our sample consisted mostly of white physicians. There were few responses from nurse practitioners and physician assistants as well as non-white providers. Future studies should focus on recruiting a more diverse sample of providers, which is especially important given the propensity of minority providers to treat minority children who are disproportionately affected by tooth decay.

Conclusion

Fluoride is important for tooth decay prevention in children. Medical providers play an important role in disseminating fluoride-related knowledge in clinical settings to caregivers, especially those who are hesitant about fluoride. Future efforts should focus on improving medical provider awareness about the benefits of various fluoride modalities and the growing prevalence of fluoride hesitancy among caregivers as well as addressing barriers to incorporating oral health activities in clinic.

Supporting information

S1 Data. Limited use data provider fluoride survey 20240709.

(CSV)

pone.0307085.s001.csv (471.5KB, csv)
S1 File. Provider survey on fluoride REDCap.

(PDF)

pone.0307085.s002.pdf (386.2KB, pdf)

Acknowledgments

We would like to thank all the participating providers for their time in completing the survey.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was supported under the National Institute of Dental and Craniofacial Research (NIH/NIDCR) grant no. R01DE026741 (PI: DLC) and by Llyod and Kay Chapman Endowed Chair for Oral Health. The funding sources had no role in the study design, collection, analysis or interpretation of data; in the writing of the report; or in the decision to submit the article for publication.

References

  • 1.Çolak H, Dülgergil Ç, Dalli M, Hamidi M. Early childhood caries update: A review of causes, diagnoses, and treatments. J Nat Sci Biol Med. 2013;4(1):29. doi: 10.4103/0976-9668.107257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Gussy MG, Waters EG, Walsh O, Kilpatrick NM. Early childhood caries: Current evidence for aetiology and prevention. J Paediatr Child Health. 2006;42(1–2):37–43. doi: 10.1111/j.1440-1754.2006.00777.x [DOI] [PubMed] [Google Scholar]
  • 3.Jackson SL, Vann WF, Kotch JB, Pahel BT, Lee JY. Impact of poor oral health on children’s school attendance and performance. Am J Public Health. 2011;101(10):1900. doi: 10.2105/AJPH.2010.200915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Singh N, Dubey N, Rathore M, Pandey P. Impact of early childhood caries on quality of life: Child and parent perspectives. J Oral Biol Craniofac Res. 2020;10(2):83. doi: 10.1016/j.jobcr.2020.02.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.American Academy of Pediatric Dentistry. Policy on early childhood caries (ECC): Classifications, consequences, and preventive strategies. American Academy of Pediatric Dentistry; 2020. [Google Scholar]
  • 6.American Academy of Pediatrics: Fluoride remains a powerful tool to prevent tooth decay.
  • 7.Sanchez OM, Childers NK. Anticipatory guidance in infant oral health: Rationale and recommendations. Am Fam Physician. 2000;61(1):115–120. Accessed August 30, 2022. https://www.aafp.org/pubs/afp/issues/2000/0101/p115.html. [PubMed] [Google Scholar]
  • 8.Chi DL, Momany ET, Jones MP, et al. Relationship between medical well baby visits and first dental examinations for young children in medicaid. Am J Public Health. 2013;103(2):347. doi: 10.2105/AJPH.2012.300899 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hagan JF, Shaw JS, Duncan PM. Bright futures: Guidelines for health supervision of infants, children, and adolescents: Pocket guide. (No Title). 2017. [Google Scholar]
  • 10.Krol DM, Segura A, Boulter S, et al. Maintaining and improving the oral health of young children. Pediatrics. 2014;134(6):1224–1229. doi: 10.1542/peds.2014-2984 [DOI] [PubMed] [Google Scholar]
  • 11.Harnagea H, Couturier Y, Shrivastava R, et al. Barriers and facilitators in the integration of oral health into primary care: A scoping review. BMJ Open. 2017;7(9). doi: 10.1136/bmjopen-2017-016078 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Marinho VC. Cochrane reviews of randomized trials of fluoride therapies for preventing dental caries. Eur Arch Paediatr Dent. 2009;10(3):183–191. doi: 10.1007/BF03262681 [DOI] [PubMed] [Google Scholar]
  • 13.Fluoride: Topical and systemic supplements | American Dental Association. Accessed January 27, 2022. https://www.ada.org/resources/research/science-and-research-institute/oral-health-topics/fluoride-topical-and-systemic-supplements.
  • 14.Clark MB, Keels MA, Slayton RL. Fluoride use in caries prevention in the primary care setting. Pediatrics. 2020;146(6). doi: 10.1542/peds.2020-034637 [DOI] [PubMed] [Google Scholar]
  • 15.Oral Health. Accessed August 30, 2022. https://www.aafp.org/about/policies/all/oral-health.html.
  • 16.Lewis CW, Grossman DC, Domoto PK, Deyo RA. The role of the pediatrician in the oral health of children: A national survey. Pediatrics. 2000;106(6). doi: 10.1542/peds.106.6.e84 [DOI] [PubMed] [Google Scholar]
  • 17.Singhal S, Figueiredo R, Dupuis S, et al. Knowledge, attitude, willingness and readiness of primary health care providers to provide oral health services to children in Niagara, Ontario: a cross-sectional survey. CMAJ Open. 2017;5(1):E249. doi: 10.9778/cmajo.20160012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Prakash P, Lawrence HP, Harvey BJ, McIsaac WJ, Limeback H, Leake JL. Early childhood caries and infant oral health: Paediatricians’ and family physicians’ knowledge, practices and training. Paediatr Child Health. 2006;11(3):151. doi: 10.1093/pch/11.3.151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ly P, Hayes DK, Yamashiroya V, Turnure MPH MM, Iwaishi LK. Knowledge and attitudes towards fluoride supplementation: A survey of pediatric medical and dental providers in the State of Hawai‘i. Hawai’i Journal of Medicine & Public Health. 2018;77(11):275. Accessed January 27, 2022. /pmc/articles/PMC6218681/. [PMC free article] [PubMed] [Google Scholar]
  • 20.Alshunaiber R, Alzaid H, Meaigel S, Aldeeri A, Adlan A. Early childhood caries and infant’s oral health; pediatricians’ and family physicians’ practice, knowledge and attitude in Riyadh city, Saudi Arabia. Saudi Dent J. 2019;31(Suppl):S96. doi: 10.1016/j.sdentj.2019.01.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chi DL. Caregivers who refuse preventive care for their children: the relationship between immunization and topical fluoride refusal. Am J Public Health. 2014;104(7):1327–1333. doi: 10.2105/AJPH.2014.301927 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Limaye RJ, Opel DJ, Dempsey A, et al. Communicating with vaccine-hesitant parents: A narrative review. Acad Pediatr. 2021;21(4S):S24–S29. doi: 10.1016/j.acap.2021.01.018 [DOI] [PubMed] [Google Scholar]
  • 23.Williams JTB, O’Leary ST, Nussbaum AM. Caring for the vaccine-hesitant family: Evidence-based alternatives to dismissal. J Pediatr. 2020;224:137. doi: 10.1016/J.JPEDS.2020.05.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Leib S, Liberatos P, Edwards K. Pediatricians’ experience with and response to parental vaccine safety concerns and vaccine refusals: A survey of connecticut pediatricians. Public Health Reports. 2011;126(Suppl 2):13. doi: 10.1177/00333549111260S203 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.O’Leary ST, Allison MA, Fisher A, et al. Characteristics of physicians who dismiss families for refusing vaccines. Pediatrics. 2015;136(6):1103–1111. doi: 10.1542/peds.2015-2086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hough-Telford C, Kimberlin DW, Aban I, et al. Vaccine delays, refusals, and patient dismissals: A survey of pediatricians. Pediatrics. 2016;138(3). doi: 10.1542/peds.2016-2127 [DOI] [PubMed] [Google Scholar]
  • 27.Chi DL, Basson AA. Surveying dentists’ perceptions of caregiver refusal of topical fluoride. JDR Clin Trans Res. 2018;3(3):314–320. doi: 10.1177/2380084418761846 [DOI] [PubMed] [Google Scholar]
  • 28.Palmada E, Gallazzini C, Barria K, Licht L, Marie-Cousin A, Sixou JL. Fluoride: changes in knowledge and prescription habits of paediatricians for 11 years in Brittany, France. European Archives of Paediatric Dentistry. 2017;18(1):51–58. doi: 10.1007/s40368-016-0267-3 [DOI] [PubMed] [Google Scholar]
  • 29.Herndon JB, Tomar SL, Lossius MN, Catalanotto FA. Preventive oral health care in early childhood: Knowledge, confidence, and practices of pediatricians and family physicians in Florida. The Journal of Pediatrics. 2010;157(6):1018–1024.e2. doi: 10.1016/j.jpeds.2010.05.045 [DOI] [PubMed] [Google Scholar]
  • 30.Goff SL, Gilson CF, DeCou E, et al. Barriers and facilitators to optimal fluoride varnish application. Academic Pediatrics. Published online October 5, 2023. doi: 10.1016/j.acap.2023.09.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Scherrer CR, Naavaal S. Cost-savings of fluoride varnish application in primary care for Medicaid-enrolled children in Virginia. J Pediatr. 2019;212:201–207.e1. doi: 10.1016/j.jpeds.2019.05.026 [DOI] [PubMed] [Google Scholar]
  • 32.Nuwarda RF, Ramzan I, Weekes L, Kayser V. Vaccine hesitancy: Contemporary issues and historical background. Vaccines (Basel). 2022;10(10):1595. doi: 10.3390/vaccines10101595 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Sudhanthar S, Lapinski J, Turner J, et al. Improving oral health through dental fluoride varnish application in a primary care paediatric practice. BMJ Open Qual. 2019;8(2). doi: 10.1136/BMJOQ-2018-000589 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Johnson SC, French GM. A auality improvement project to optimize fluoride varnish use in a pediatric outpatient clinic with multiple resident providers. Hawaii J Health Soc Welf. 2020;79(5 Suppl 1):7. Accessed January 27, 2022. /pmc/articles/PMC7260867/. [PMC free article] [PubMed] [Google Scholar]
  • 35.Braun PA, Cusick A. Collaboration between medical providers and dental hygienists in pediatric health care. J Evid Based Dent Pract. 2016;16 Suppl:59–. doi: 10.1016/j.jebdp.2016.01.017 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Hadi Ghasemi

16 Jun 2024

PONE-D-24-16749A cross-sectional study of pediatric and family medicine providers on fluoride-related beliefs and practices, and experiences with fluoride-hesitant caregiversPLOS ONE

Dear Dr. Chi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 31 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.<br30june, 2024.="" complete="" if="" more="" need="" revisions="" than="" this="" time="" to="" will="" you="" your="">

Please include the following items when submitting your revised manuscript:</br30june,>

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Hadi Ghasemi

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and its Supporting Information files.

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: As a reviewer, I find several strengths and areas for improvement in the study on fluoride-related beliefs and practices among pediatric and family medicine providers.

Strengths:

Clear Objectives and Findings Presentation: The study clearly outlines its objectives and presents its findings in a structured manner, making it easy for readers to understand the research aims and outcomes.

Relevant and Timely Topic: With increasing concerns about fluoride hesitancy among caregivers, especially mirroring vaccine hesitancy, the study addresses a pertinent issue in pediatric and family medicine practice.

Insightful Comparison between Specialties: The comparison between pediatric and family medicine providers provides valuable insights into potential differences in knowledge, beliefs, and practices regarding fluoride recommendations.

Identification of Barriers: The study effectively identifies common barriers to incorporating oral health activities into medical practice, particularly the lack of time, which is a practical concern for many healthcare providers.

Practical Implications: By highlighting the need to improve medical provider awareness about the benefits of fluoride and addressing fluoride hesitancy among caregivers, the study offers practical implications for enhancing preventive dental care in clinical settings.

Areas for Improvement:

Sampling Limitations: The use of convenience sampling in two states and the predominantly white physician sample limit the generalizability of the findings. Future studies should strive for more diverse and representative samples to ensure broader applicability of the results, especially considering the disproportionate impact of tooth decay on minority children.

Quantitative Data Analysis: While the study provides valuable quantitative data on providers' beliefs and practices, it would benefit from more robust statistical analyses to strengthen the validity and reliability of the findings.

Qualitative Insights: Incorporating qualitative methods, such as interviews or focus groups, could provide deeper insights into the reasons behind providers' beliefs, practices, and perceived barriers, enriching the understanding of fluoride-related attitudes in clinical practice.

Recommendation Strategies: While the study mentions the need to explore strategies for addressing fluoride hesitancy, it could elaborate further on specific intervention approaches or educational programs that could be implemented in medical settings to improve fluoride-related practices.

Addressing these areas for improvement could enhance the rigor and comprehensiveness of the study, thereby strengthening its contribution to the literature on preventive dental care in pediatric and family medicine.

Best Regards

Reviewer #2: Dear Author

Good time

It was a pleasure to read the article. It is generally well written and of clinical and public value. However, there are few comments that will enrich the article and increases its academic value.

Generally, it is of clinical value at the public level and tackles an important subject. It needs to be presented in a better easy way and use simpler language

Title: It is too long and not easy to understand, make it simpler and to the point

Abstract: Generally well written and presented with no serious comments.

Introduction: it is fine but too long and contains many sentences that need to be in the discussion.

1- lines 55-58 not easy to understand, needs rewriting

2-lines 73-77 do not have references!!! are they your results??

3- lines 81-85 as above

Methodology: overall is acceptable but attention is to be paid for the below points ;

1-instead of the heading : study participants it is better to be: study design, setting and participants

2- Need to make a flow chart for your methodology

3-the grouping is not clear, make them consistent throughout the study, are they two groups or more ?

4- PLEASE USE SIMPLE CLEAR LANGUAGE THAT DELIVERS THE MEANING

Results: Not easy to understand so PLEASE MAKE IT EASY

1- Lines 231-233 not clear

2- Table 1: regarding age I am not sure if the mean of the age has percentage !!!

3- Table 1: Why Hispanic is not part of the race and is a separate entity???

Discussion : acceptable with logical flow of the section but it seems to be slightly long

Conclusion: reasonable and not extravagant

Reviewer #3: Dear authors,

Thanks for sharing your work with us, some points should be kept in consideration:

1.The manuscript within the scope of the journal.

2.Both the quality and data presentation of this manuscript are good and of great importance to dentists, physicians and even patients.

3.The manuscript expands our knowledge about fluoride-related beliefs and practices

4.The title should be revised and reduced its characters ( precise & and informative)

5.The abstract should reflect the content of the article and must be with range of 250-300 words.

6.more paragraphs should be incorporated to introduction and discussion about the justification of your findings and comparison with other recent relevant studies.

7.Up to date references should be kept in your reference list and the old should be omitted.

Good Luck

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Bassam Alsheekhly

Reviewer #2: No

Reviewer #3: Yes: Tahrir Aldelaimi

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-24-16749_reviewer.docx

pone.0307085.s003.docx (13.4KB, docx)
PLoS One. 2024 Jul 19;19(7):e0307085. doi: 10.1371/journal.pone.0307085.r002

Author response to Decision Letter 0


17 Jun 2024

Dear Dr. Ghasemi,

We are pleased to submit our revised paper. Below we provide detailed responses to each of the reviewer’s comments. Responses are indicated below. Thank you very much.

Sincerely,

Donald Chi

I thank the editor for providing this opportunity to participate in the manuscript review

As a reviewer, I find several strengths and areas for improvement in the study on fluoride-related beliefs and practices among pediatric and family medicine providers.

Thank you very much.

Strengths:

Clear Objectives and Findings Presentation: The study clearly outlines its objectives and presents its findings in a structured manner, making it easy for readers to understand the research aims and outcomes.

Thank you.

Relevant and Timely Topic: With increasing concerns about fluoride hesitancy among caregivers, especially mirroring vaccine hesitancy, the study addresses a pertinent issue in pediatric and family medicine practice.

We agree.

Insightful Comparison between Specialties: The comparison between pediatric and family medicine providers provides valuable insights into potential differences in knowledge, beliefs, and practices regarding fluoride recommendations.

Thank you.

Identification of Barriers: The study effectively identifies common barriers to incorporating oral health activities into medical practice, particularly the lack of time, which is a practical concern for many healthcare providers.

Thank you.

Practical Implications: By highlighting the need to improve medical provider awareness about the benefits of fluoride and addressing fluoride hesitancy among caregivers, the study offers practical implications for enhancing preventive dental care in clinical settings.

Thank you.

Areas for Improvement:

Sampling Limitations: The use of convenience sampling in two states and the predominantly white physician sample limit the generalizability of the findings. Future studies should strive for more diverse and representative samples to ensure broader applicability of the results, especially considering the disproportionate impact of tooth decay on minority children.

We agree. These are noted as the two main limitations in the Discussion section.

Quantitative Data Analysis: While the study provides valuable quantitative data on providers' beliefs and practices, it would benefit from more robust statistical analyses to strengthen the validity and reliability of the findings.

This was a descriptive study to evaluate physicians’ views on fluoride hesitancy. Since it is the first such study, our goal was to describe their views and see if there are potential differences by medical provide type. The statistical methods employed were sufficient for these goals. We look forward to using more complex statistical methods in the future to answer more complex study hypotheses.

Qualitative Insights: Incorporating qualitative methods, such as interviews or focus groups, could provide deeper insights into the reasons behind providers' beliefs, practices, and perceived barriers, enriching the understanding of fluoride-related attitudes in clinical practice.

We agree. We hope to incorporate qualitative methods into future investigations.

Recommendation Strategies: While the study mentions the need to explore strategies for addressing fluoride hesitancy, it could elaborate further on specific intervention approaches or educational programs that could be implemented in medical settings to improve fluoride-related practices.

We do not currently have evidence-based strategies to address fluoride hesitancy in dental settings, which precludes our team from recommending strategies for use in medical settings. We do discuss the possibility of incorporating dental hygienists in medical practice settings, which has been shown to be effective in some clinics. Future work will hopefully continue to help clarify what these approaches are.

Addressing these areas for improvement could enhance the rigor and comprehensiveness of the study, thereby strengthening its contribution to the literature on preventive dental care in pediatric and family medicine.

Thank you again.

Best Regards

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: As a reviewer, I find several strengths and areas for improvement in the study on fluoride-related beliefs and practices among pediatric and family medicine providers.

Strengths:

Clear Objectives and Findings Presentation: The study clearly outlines its objectives and presents its findings in a structured manner, making it easy for readers to understand the research aims and outcomes.

Thank you.

Relevant and Timely Topic: With increasing concerns about fluoride hesitancy among caregivers, especially mirroring vaccine hesitancy, the study addresses a pertinent issue in pediatric and family medicine practice.

We agree.

Insightful Comparison between Specialties: The comparison between pediatric and family medicine providers provides valuable insights into potential differences in knowledge, beliefs, and practices regarding fluoride recommendations.

Thank you.

Identification of Barriers: The study effectively identifies common barriers to incorporating oral health activities into medical practice, particularly the lack of time, which is a practical concern for many healthcare providers.

Agreed.

Practical Implications: By highlighting the need to improve medical provider awareness about the benefits of fluoride and addressing fluoride hesitancy among caregivers, the study offers practical implications for enhancing preventive dental care in clinical settings.

Thank you.

Areas for Improvement:

Sampling Limitations: The use of convenience sampling in two states and the predominantly white physician sample limit the generalizability of the findings. Future studies should strive for more diverse and representative samples to ensure broader applicability of the results, especially considering the disproportionate impact of tooth decay on minority children.

We agree. These are noted as the two main limitations in the Discussion section.

Quantitative Data Analysis: While the study provides valuable quantitative data on providers' beliefs and practices, it would benefit from more robust statistical analyses to strengthen the validity and reliability of the findings.

This was a descriptive study to evaluate physicians’ views on fluoride hesitancy. Since it is the first such study, our goal was to describe their views and see if there are potential differences by medical provide type. The statistical methods employed were sufficient for these goals. We look forward to using more complex statistical methods in the future to answer more complex study hypotheses.

Qualitative Insights: Incorporating qualitative methods, such as interviews or focus groups, could provide deeper insights into the reasons behind providers' beliefs, practices, and perceived barriers, enriching the understanding of fluoride-related attitudes in clinical practice.

We agree. We hope to incorporate qualitative methods into future investigations.

Recommendation Strategies: While the study mentions the need to explore strategies for addressing fluoride hesitancy, it could elaborate further on specific intervention approaches or educational programs that could be implemented in medical settings to improve fluoride-related practices.

We do not currently have evidence-based strategies to address fluoride hesitancy in dental settings, which precludes our team from recommending strategies for use in medical settings. We do discuss the possibility of incorporating dental hygienists in medical practice settings, which has been shown to be effective in some clinics. Future work will hopefully continue to help clarify what these approaches are.

Addressing these areas for improvement could enhance the rigor and comprehensiveness of the study, thereby strengthening its contribution to the literature on preventive dental care in pediatric and family medicine.

Thank you again.

Best Regards

Reviewer #2: Dear Author

Good time

It was a pleasure to read the article. It is generally well written and of clinical and public value. However, there are few comments that will enrich the article and increases its academic value.

Generally, it is of clinical value at the public level and tackles an important subject. It needs to be presented in a better easy way and use simpler language

Title: It is too long and not easy to understand, make it simpler and to the point

We shortened the title as suggested.

Abstract: Generally well written and presented with no serious comments.

Introduction: it is fine but too long and contains many sentences that need to be in the discussion.

1- lines 55-58 not easy to understand, needs rewriting

The sentence length has been reduced.

2-lines 73-77 do not have references!!! are they your results??

The sentences without references have been removed.

3- lines 81-85 as above

Ditto as above.

Methodology: overall is acceptable but attention is to be paid for the below points ;

1-instead of the heading : study participants it is better to be: study design, setting and participants

The section has been relabeled.

2- Need to make a flow chart for your methodology

We believe the methodology is straightforward and therefore chose not to include a flow chart.

3-the grouping is not clear, make them consistent throughout the study, are they two groups or more ?

There are 2 groups. This is clarified in the revised paper.

4- PLEASE USE SIMPLE CLEAR LANGUAGE THAT DELIVERS THE MEANING

Results: Not easy to understand so PLEASE MAKE IT EASY

1- Lines 231-233 not clear

These are findings directly presented in the table and are self-explanatory. Clarified that Medicaid means publicly-insured.

2- Table 1: regarding age I am not sure if the mean of the age has percentage !!!

These are mean (SD) as indicated at the top of the Table.

3- Table 1: Why Hispanic is not part of the race and is a separate entity???

Hispanic ethnicity is a separate variable from race in the U.S.

Discussion : acceptable with logical flow of the section but it seems to be slightly long

Conclusion: reasonable and not extravagant

Reviewer #3: Dear authors,

Thanks for sharing your work with us, some points should be kept in consideration:

1.The manuscript within the scope of the journal.

Thank you.

2.Both the quality and data presentation of this manuscript are good and of great importance to dentists, physicians and even patients.

Thank you very much.

3.The manuscript expands our knowledge about fluoride-related beliefs and practices

We agree.

4.The title should be revised and reduced its characters ( precise & and informative)

The title has been shortened.

5.The abstract should reflect the content of the article and must be with range of 250-300 words.

The abstract length was increased to 253 words.

6.more paragraphs should be incorporated to introduction and discussion about the justification of your findings and comparison with other recent relevant studies.

All of the available studies have been cited in both sections, and comparisons are made whenever possible.

7.Up to date references should be kept in your reference list and the old should be omitted.

The cited references are the ones that are most up to date and more importantly only relevant references are cited.

Good Luck

Thank you!

________________________________________

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Bassam Alsheekhly

Reviewer #2: No

Reviewer #3: Yes: Tahrir Aldelaimi

Decision Letter 1

Hadi Ghasemi

1 Jul 2024

A cross-sectional study of physicians on fluoride-related beliefs and practices, and experiences with fluoride-hesitant caregivers

PONE-D-24-16749R1

Dear Dr. Donald L. Chi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Hadi Ghasemi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Dear Author

You addressed my concern. The work is of significant scientific merit

Wishing you the best in your academia and clinical work

Reviewer #3: Dear authors

Thanks for sharing your work with us, the authors have performing all the suggested comments and revisions.

Good Luck

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: Yes: Tahrir N Aldelaimi

**********

Acceptance letter

Hadi Ghasemi

11 Jul 2024

PONE-D-24-16749R1

PLOS ONE

Dear Dr. Chi,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Hadi Ghasemi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data. Limited use data provider fluoride survey 20240709.

    (CSV)

    pone.0307085.s001.csv (471.5KB, csv)
    S1 File. Provider survey on fluoride REDCap.

    (PDF)

    pone.0307085.s002.pdf (386.2KB, pdf)
    Attachment

    Submitted filename: PONE-D-24-16749_reviewer.docx

    pone.0307085.s003.docx (13.4KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES